Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To determine whether long-term maintenance therapy with a single drug (Myfortic) applied
using advanced immunologic monitoring tools in selected patients can lead to superior native
kidney function at 2 years without resulting in increased acute rejection episodes or
deterioration of liver allograft function.